More articles from Articles

You have access
A Computational-Based Approach to Identify Estrogen Receptor α/β Heterodimer Selective Ligands
Carlos G. Coriano, Fabao Liu, Chelsie K. Sievers, Muxuan Liang, Yidan Wang, Yoongho Lim, Menggang Yu and Wei Xu

Molecular Pharmacology March 2018, 93 (3) 197-207; DOI: https://doi.org/10.1124/mol.117.108696
You have access
Activation of Constitutive Androstane Receptor Ameliorates Renal Ischemia-Reperfusion–Induced Kidney and Liver Injury
You-Jin Choi, Dong Zhou, Anne Caroline S. Barbosa, Yongdong Niu, Xiudong Guan, Meishu Xu, Songrong Ren, Thomas D. Nolin, Youhua Liu and Wen Xie

Molecular Pharmacology March 2018, 93 (3) 239-250; DOI: https://doi.org/10.1124/mol.117.111146
You have access
Evaluation of the Selectivity and Cysteine Dependence of Inhibitors across the Regulator of G Protein–Signaling Family
Michael P. Hayes, Christopher R. Bodle and David L. Roman

Molecular Pharmacology January 2018, 93 (1) 25-35; DOI: https://doi.org/10.1124/mol.117.109843
You have access
Human Missense Mutations in Regulator of G Protein Signaling 2 Affect the Protein Function Through Multiple Mechanisms
Hoa T.N. Phan, Benita Sjögren and Richard R. Neubig

Molecular Pharmacology October 2017, 92 (4) 451-458; DOI: https://doi.org/10.1124/mol.117.109215
You have access
A Novel Selective Inverse Agonist of the CB₂ Receptor as a Radiolabeled Tool Compound for Kinetic Binding Studies
Andrea Martella, Huub Sijben, Arne C. Rufer, Uwe Grether, Juergen Fingerle, Christoph Ullmer, Thomas Hartung, Adriaan P. IJzerman, Mario van der Stelt and Laura H. Heitman

Molecular Pharmacology October 2017, 92 (4) 389-400; DOI: https://doi.org/10.1124/mol.117.108605
You have access
A Functional Na_V1.7-Na_VAb Chimera with a Reconstituted High-Affinity ProTx-II Binding Site
Ramkumar Rajamani, Sophie Wu, Iyoncy Rodrigo, Mian Gao, Simon Low, Lisa Megson, David Wensel, Rick L. Pieschl, Debra J. Post-Munson, John Watson, David R. Langley, Michael K. Ahlijanian, Linda J. Bristow and James Herrington

Molecular Pharmacology September 2017, 92 (3) 310-317; DOI: https://doi.org/10.1124/mol.117.108712
You have access
Thiosemicarbazones Functioning as Zinc Metallochaperones to Reactivate Mutant p53
Xin Yu, Adam Blanden, Ashley T. Tsang, Saif Zaman, Yue Liu, John Gilleran, Anthony F. Bencivenga, S. David Kimball, Stewart N. Loh and Darren R. Carpizo

Molecular Pharmacology June 2017, 91 (6) 567-575; DOI: https://doi.org/10.1124/mol.116.107409
You have access
Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics
Ni Li, Xiao Wang, Yanni Xu, Yuan Lin, Ningyu Zhu, Peng Liu, Duo Lu and Shuyi Si

Molecular Pharmacology April 2017, 91 (4) 264-276; DOI: https://doi.org/10.1124/mol.116.105213
You have access
Molecular Interactions and Implications of Aldose Reductase Inhibition by PGA₁ and Clinically Used Prostaglandins
Beatriz Díez-Dacal, Francisco J. Sánchez-Gómez, Pedro A. Sánchez-Murcia, Ivana Milackova, Tahl Zimmerman, Jana Ballekova, Elena García-Martín, José A. G. Agúndez, Severine Gharbi, Federico Gago, Milan Stefek and Dolores Pérez-Sala

Molecular Pharmacology January 2016, 89 (1) 42-52; DOI: https://doi.org/10.1124/mol.115.100693
You have access
Salmeterol’s Extreme β2 Selectivity Is Due to Residues in Both Extracellular Loops and Transmembrane Domains
Jillian G. Baker, Richard G. W. Proudman and Stephen J. Hill

Molecular Pharmacology January 2015, 87 (1) 103-120; DOI: https://doi.org/10.1124/mol.114.095364

Main menu

User menu

Search

More articles from Articles

Pages

Navigate

More Information

ASPET's Other Journals